Potential for Energy Production from Farm Wastes Using Anaerobic Digestion in the UK: An Economic Comparison of Different Size Plants

© 2017 by the authors. Anaerobic digestion (AD) plants enable renewable fuel, heat, and electricity production, with their efficiency and capital cost strongly dependent on their installed capacity. In this work, the technical and economic feasibility of different scale AD combined heat and power (CHP) plants was analyzed. Process configurations involving the use of waste produced in different farms as feedstock for a centralized AD plant were assessed too. The results show that the levelized cost of electricity are lower for large-scale plants due to the use of more efficient conversion devices and their lower capital cost per unit of electricity produced. The levelized cost of electricity was estimated to be 4.3 p/kWhe for AD plants processing the waste of 125 dairy cow sized herds compared to 1.9 p/kWhe for AD plants processing waste of 1000 dairy cow sized herds. The techno-economic feasibility of the installation of CO2 capture units in centralized AD-CHP plants was also undertaken. The conducted research demonstrated that negative CO2 emission AD power generation plants could be economically viable with currently paid feed-in tariffs in the UK.The authors would like to acknowledge the funding received from the Research Councils UK (RCUK) and particularly the Engineering and Physical Sciences Research Council (EPSRC) under Grant Number: EP/K011820/1 (Centre for Sustainable Energy Use in Food Chains-CSEF) and EP/M007359/1 (Recovery and re-use of energy, water and nutrients from waste in the food chain-Redivivus)

A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism

Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family, are believed to regulate metabolic physiology. Genetic mouse models have established C16 ceramide as a driver of insulin resistance in liver and adipose tissue. C18 ceramide, synthesized by ceramide synthase 1 (CerS1), is abundant in skeletal muscle and suggested to promote insulin resistance in humans. We herein describe the first isoform-specific ceramide synthase inhibitor, P053, which inhibits CerS1 with nanomolar potency. Lipidomic profiling shows that P053 is highly selective for CerS1. Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity, but does not protect against HFD-induced insulin resistance. Our inhibitor therefore allowed us to define a role for CerS1 as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity

A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism

Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family, are believed to regulate metabolic physiology. Genetic mouse models have established C16 ceramide as a driver of insulin resistance in liver and adipose tissue. C18 ceramide, synthesized by ceramide synthase 1 (CerS1), is abundant in skeletal muscle and suggested to promote insulin resistance in humans. We herein describe the first isoform-specific ceramide synthase inhibitor, P053, which inhibits CerS1 with nanomolar potency. Lipidomic profiling shows that P053 is highly selective for CerS1. Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity, but does not protect against HFD-induced insulin resistance. Our inhibitor therefore allowed us to define a role for CerS1 as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity

Nutrigenomics as strategy for neuronal health

Nutrigenomics through gene expression and epigenetic remodeling can program adult health. Diet during pregnancy and lactation (the first 1000 days of life) can modulate offspring’s epigenome leading to tissue specific variations during cell differentiation processes, and may define epigenetic marks associated with longterm effects on offspring neuronal health. Being epigenetics reversible, a healthy diet represents a fundamental opportunity, even after the first 1000 days of life, for maintaining cellular homeostasis. The positive impact of food (i.e. maternal milk, oily fish, fruit and vegetables, curcumin, tea) with its dietary flavonoids (i.e. sulforaphane, quercetin, lutein, resveratrol, carotenoids) and other bioactive compounds (i.e. docosahexanoic acid, melatonin etc.), will be reflected on chromatin structure modulation and DNA methylation which are associated with switching on/off of genes. An anti-inflammatory diet during early-life and across the whole life may represent a key strategy for influencing brain plasticity and for building an “epigenetic memory” useful in developing neuronal resilience against early-life stressors and to prevent age-related neurodegeneration